TPAs · PBMs · Cost Containment · Brokers · Self-Insured Employers

Cut GLP-1 and specialty drug spend 30–70% — from Canada, at 2–8°C.

ColdRxMeds is the documented Canadian sourcing layer that sits alongside your existing program. Same brand-name therapies, dramatically lower cost, compliance documentation on every order — and zero disruption to your formulary, your PBM, or your members.

🍁 CANADA-ONLY SOURCING 30–70% DAY-1 SAVINGS MANITOBA IPS LICENSED · CREDENTIALS AT ONBOARDING DOCUMENTED ON EVERY ORDER
The Problem

A handful of drugs are eating your plan.

GLP-1s, biologics, and specialty injectables are the fastest-growing — and least-controlled — line in nearly every self-funded plan. The cost variance on the identical molecule is wider here than anywhere else in pharmacy.

~50%

of drug spend is specialty

A small share of claimants now drives roughly half of total pharmacy cost for most plans.

10%+

of claims are GLP-1s

And climbing fast as indications expand — with U.S. pricing untethered from the rest of the world.

30–70%

lower, sourced from Canada

The same brand-name drug, same manufacturer — at a fraction of the U.S. cost, fully documented.

Who We Serve

Built for whoever owns the hardest line item in benefits.

Whether you administer the plan, manage the pharmacy benefit, advise the employer, or sign the checks — this was built to make your specialty number smaller without making your job harder.

Self-Insured Employers · CFO & CHRO

Recover budget without touching benefits.

Your specialty line grows faster than anything else in the plan. ColdRxMeds restates its cost basis — same medications, same prescribers, dramatically lower spend — with documentation built for board and legal review.

For the CFO
  • 30–70% verified savings from the first fill
  • Audit-ready dispensing records, every order
  • Monthly drug-by-drug savings reporting
  • No upfront cost, no plan redesign
For the CHRO
  • Same brand-name medication, same maker
  • Members keep their doctor and prescription
  • Voluntary opt-in — nothing taken away
  • Cold-chain delivery to the member's door
Cost Containment Firms

Your specialty sourcing engine.

Add a documented Canadian sourcing layer to your program. We handle dispensing, cold chain, and compliance documentation — you deliver the savings under your own banner.

PBMs & TPAs

Zero disruption. Instant overlay.

We plug into your existing formulary and plan design — no rip-and-replace, no EDI work. DIN-to-NDC matching confirms therapeutic equivalence on every specialty drug.

Brokers & Consultants

The tool your clients haven't seen.

Canadian sourcing is the international option you can defend at the regulatory level — and prove to a skeptical CFO. Bring documented savings to your next renewal.

The Member Experience

Nothing changes for the member. That's the point.

Cost programs fail when employees feel them. This one is designed to be invisible to your people — except for what they stop paying.

01

Same medication

Brand-name only, same manufacturer, same formulation. No generic substitution, no compounding — ever.

02

Same doctor

Members keep their prescriber and prescription. A licensed pharmacist reviews every order before it ships.

03

Door delivery, kept cold

Validated 2–8°C packaging on every temperature-sensitive order, tracked end to end.

04

Always voluntary

Members opt in. Nothing is removed from the plan — the program simply adds a lower-cost path.

How It Works

A carve-out that plugs in, not rips out.

01

Identify

You flag the high-cost specialty members and drugs. We return a documented savings analysis in 48 hours.

02

Enroll

Eligible members opt in. Their prescriber sends the prescription into the program.

03

Dispense & ship

A licensed pharmacist reviews every order; medication ships cold-chain, pharmacy-direct to the member.

04

Invoice & report

One monthly invoice, every line tied to a dispensing record. Savings reporting your CFO can present.

See your specialty spend, restated.

Send us your top specialty medications and approximate member counts. We return a custom savings analysis within 48 hours — drug by drug, methodology documented, ready for a CFO or a board.

Request Your Free Savings Analysis →
No commitment · No pitch deck · Just the numbers